• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C型利钠肽诱导血管平滑肌细胞再分化并加速内皮再形成。

C-type natriuretic peptide induces redifferentiation of vascular smooth muscle cells with accelerated reendothelialization.

作者信息

Doi K, Ikeda T, Itoh H, Ueyama K, Hosoda K, Ogawa Y, Yamashita J, Chun T H, Inoue M, Masatsugu K, Sawada N, Fukunaga Y, Saito T, Sone M, Yamahara K, Kook H, Komeda M, Ueda M, Nakao K

机构信息

Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan.

出版信息

Arterioscler Thromb Vasc Biol. 2001 Jun;21(6):930-6. doi: 10.1161/01.atv.21.6.930.

DOI:10.1161/01.atv.21.6.930
PMID:11397699
Abstract

We recently reported that C-type natriuretic peptide (CNP) occurs in vascular endothelial cells and acts as a vascular-type natriuretic peptide. In the present study, we stimulated the cGMP cascade in proliferating smooth muscle cells (SMCs), in which particulate guanylate cyclase-B, the specific receptor for CNP, is predominantly expressed, by use of an adenovirus encoding rat CNP cDNA (Ad.CNP). In the Ad.CNP-treated cultured SMCs, CNP caused the growth inhibition of SMCs at G(1) phase with an early increase of p21(CIP1/WAF1) expression and subsequent upregulation of p16(INK4a). The expression of smooth muscle myosin heavy chain-2, which is the molecular marker of highly differentiated SMCs, was reinduced in the Ad.CNP-treated SMCs. The Ad.CNP-treated SMCs also reexpressed particulate guanylate cyclase-A, which shows high affinity to atrial and brain natriuretic peptide and is exclusively expressed in well-differentiated SMCs. CNP, which was overexpressed in rabbit femoral arteries in vivo at the time of balloon injury, significantly suppressed neointimal formation. Furthermore, an enhancement of the expression of smooth muscle myosin heavy chain-2 occurred in the residual neointima. In addition, early regeneration of endothelial cells was observed in the Ad.CNP-infected group. Thus, stimulation of cGMP cascade in proliferating dedifferentiated SMCs can induce growth inhibition and redifferentiation of SMCs with accelerated reendothelialization.

摘要

我们最近报道,C型利钠肽(CNP)存在于血管内皮细胞中,并作为一种血管型利钠肽发挥作用。在本研究中,我们通过使用编码大鼠CNP cDNA的腺病毒(Ad.CNP)刺激增殖的平滑肌细胞(SMC)中的cGMP级联反应,其中颗粒型鸟苷酸环化酶-B(CNP的特异性受体)在该细胞中主要表达。在经Ad.CNP处理的培养SMC中,CNP在G1期导致SMC生长抑制,p21(CIP1/WAF1)表达早期增加,随后p16(INK4a)上调。平滑肌肌球蛋白重链-2(高度分化的SMC的分子标志物)的表达在经Ad.CNP处理的SMC中重新诱导。经Ad.CNP处理的SMC还重新表达颗粒型鸟苷酸环化酶-A,其对心房利钠肽和脑利钠肽具有高亲和力,且仅在分化良好的SMC中表达。在体内球囊损伤时兔股动脉中过表达的CNP显著抑制了新生内膜形成。此外,在残留的新生内膜中平滑肌肌球蛋白重链-2的表达增强。另外,在Ad.CNP感染组中观察到内皮细胞的早期再生。因此,刺激增殖的去分化SMC中的cGMP级联反应可诱导SMC生长抑制和再分化,并加速内皮再形成。

相似文献

1
C-type natriuretic peptide induces redifferentiation of vascular smooth muscle cells with accelerated reendothelialization.C型利钠肽诱导血管平滑肌细胞再分化并加速内皮再形成。
Arterioscler Thromb Vasc Biol. 2001 Jun;21(6):930-6. doi: 10.1161/01.atv.21.6.930.
2
Adenovirus-mediated gene transfer of C-type natriuretic peptide causes G1 growth inhibition of cultured vascular smooth muscle cells.腺病毒介导的C型利钠肽基因转移导致培养的血管平滑肌细胞G1期生长抑制。
Biochem Biophys Res Commun. 1997 Oct 29;239(3):889-94. doi: 10.1006/bbrc.1997.7576.
3
Accelerated reendothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of C-type natriuretic peptide.通过腺病毒介导的C型利钠肽基因转移促进兔颈静脉移植物的再内皮化,同时抑制其血栓形成特性和内膜增生。
Circulation. 2002 Apr 9;105(14):1623-6. doi: 10.1161/01.cir.0000014985.50017.6e.
4
Functional analysis of genomic DNA, cDNA, and nucleotide sequence of the mature C-type natriuretic peptide gene in vascular cells.血管细胞中成熟C型利钠肽基因的基因组DNA、cDNA及核苷酸序列的功能分析
Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1646-51. doi: 10.1161/01.ATV.0000137387.78515.61. Epub 2004 Jul 1.
5
Regulation of endothelial production of C-type natriuretic peptide in coculture with vascular smooth muscle cells. Role of the vascular natriuretic peptide system in vascular growth inhibition.与血管平滑肌细胞共培养时内皮细胞C型利钠肽生成的调节。血管利钠肽系统在血管生长抑制中的作用。
Circ Res. 1996 Apr;78(4):606-14. doi: 10.1161/01.res.78.4.606.
6
C-Type natriuretic peptide and natriuretic peptide receptors are expressed by smooth muscle cells in the neointima after percutaneous coronary intervention.C型利钠肽和利钠肽受体在经皮冠状动脉介入术后新生内膜的平滑肌细胞中表达。
Atherosclerosis. 2005 Aug;181(2):241-50. doi: 10.1016/j.atherosclerosis.2005.01.023. Epub 2005 Mar 5.
7
Increase of C-type natriuretic peptide expression by serum and platelet-derived growth factor-BB in human aortic smooth muscle cells is dependent on protein kinase C activation.血清和血小板衍生生长因子-BB 对人主动脉平滑肌细胞中 C 型利钠肽表达的增加依赖于蛋白激酶 C 的激活。
Endocrinology. 2006 Sep;147(9):4169-78. doi: 10.1210/en.2006-0239. Epub 2006 Jun 15.
8
Natriuretic peptide receptor-3 underpins the disparate regulation of endothelial and vascular smooth muscle cell proliferation by C-type natriuretic peptide.利钠肽受体 3 介导 C 型利钠肽对血管内皮和平滑肌细胞增殖的不同调节作用。
Br J Pharmacol. 2011 Sep;164(2b):584-97. doi: 10.1111/j.1476-5381.2011.01400.x.
9
Expression and control of C-type natriuretic peptide in rat vascular smooth muscle cells.大鼠血管平滑肌细胞中C型利钠肽的表达与调控
Am J Physiol Regul Integr Comp Physiol. 2002 Jan;282(1):R156-65. doi: 10.1152/ajpregu.2002.282.1.R156.
10
Expression and localization of C-type natriuretic peptide in human vascular smooth muscle cells.C型利钠肽在人血管平滑肌细胞中的表达与定位
Vascul Pharmacol. 2006 Dec;45(6):368-73. doi: 10.1016/j.vph.2006.06.011. Epub 2006 Jun 22.

引用本文的文献

1
Heart failure is the most negative consequence of CABG surgery (importance of exercise rehabilitation approach).心力衰竭是冠状动脉旁路移植术最不利的后果(运动康复方法的重要性)。
ARYA Atheroscler. 2025;21(3):59-74. doi: 10.48305/arya.2025.42587.2953.
2
Celebrating the 100 anniversary of the Japan Endocrine Society: reflecting on my 50 years of hormone research.庆祝日本内分泌学会成立100周年:回顾我50年的激素研究历程。
Endocr J. 2025;72(1):1-21. doi: 10.1507/endocrj.EJ20241105.
3
Discovery of small molecule guanylyl cyclase B receptor positive allosteric modulators.
小分子鸟苷酸环化酶B受体正变构调节剂的发现。
PNAS Nexus. 2024 Jun 6;3(6):pgae225. doi: 10.1093/pnasnexus/pgae225. eCollection 2024 Jun.
4
Experimental conditions and protein markers for redifferentiation of human coronary artery smooth muscle cells.人冠状动脉平滑肌细胞再分化的实验条件和蛋白质标志物
Biomed Rep. 2023 Feb 13;18(3):24. doi: 10.3892/br.2023.1606. eCollection 2023 Mar.
5
N-terminal pro-brain natriuretic peptide and coronary collateral formation in patients undergoing primary percutaneous coronary intervention.N 端脑利钠肽前体与经皮冠状动脉介入治疗患者冠状动脉侧支循环的形成。
Heart Vessels. 2021 Dec;36(12):1775-1783. doi: 10.1007/s00380-021-01866-3. Epub 2021 May 28.
6
C-type Natriuretic Peptide: A Multifaceted Paracrine Regulator in the Heart and Vasculature.C 型利钠肽:心脏和血管中的多功能旁分泌调节剂。
Int J Mol Sci. 2019 May 8;20(9):2281. doi: 10.3390/ijms20092281.
7
Endothelial C-Type Natriuretic Peptide Is a Critical Regulator of Angiogenesis and Vascular Remodeling.内皮 C 型利钠肽是血管生成和血管重构的关键调节因子。
Circulation. 2019 Mar 26;139(13):1612-1628. doi: 10.1161/CIRCULATIONAHA.118.036344.
8
N-Terminal pro C-Type Natriuretic Peptide (NTproCNP) and myocardial function in ageing.N 端脑利钠肽前体(NTproCNP)与衰老心肌功能。
PLoS One. 2018 Dec 19;13(12):e0209517. doi: 10.1371/journal.pone.0209517. eCollection 2018.
9
Natriuretic peptide based therapeutics for heart failure: Cenderitide: A novel first-in-class designer natriuretic peptide.基于利钠肽的心力衰竭治疗药物:西那肽:一种新型的首创类设计利钠肽。
Int J Cardiol. 2019 Apr 15;281:166-171. doi: 10.1016/j.ijcard.2018.06.002. Epub 2018 Jun 3.
10
Overexpression of C-type Natriuretic Peptide in Endothelial Cells Protects against Insulin Resistance and Inflammation during Diet-induced Obesity.内皮细胞中 C 型利钠肽的过表达可预防饮食诱导肥胖期间的胰岛素抵抗和炎症。
Sci Rep. 2017 Aug 29;7(1):9807. doi: 10.1038/s41598-017-10240-1.